VeonGen Therapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

VeonGen Therapeutics at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
VeonGen Therapeutics
Munich, Germany
veongen.com
Biotech
Clinical-stage company developing AAV gene therapies for inherited retinal diseases, led by a Stargardt disease program.
Panel
Mon Nov 9
16:00–16:45
Cell and Gene Therapy: What Should You Know?
Where cell and gene therapies stand today, what recent clinical and sales data show, and how funding and partnerships are changing.
with Form Bio, Sofinnova Partners, BioM

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from VeonGen Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction